A project manager is developing the risk management plan for a new pharmaceutical drug development project. The sponsor has emphasized that while innovation is key, the project must not jeopardize regulatory approval. This implies a very low tolerance for any risks related to compliance and safety. Which component of the risk management plan is MOST directly concerned with defining these acceptable levels of risk-taking?
-
A
Risk categories
-
B
Methodology
-
C
Stakeholder risk appetite and thresholds
-
D
Roles and responsibilities